Search Results - Yan‐Jiang Wang
- Showing 1 - 3 results of 3
-
1
Join us on an amazing journey towards next‐generation treatments for CNS disorders: Launch of Neuroprotection, a new high‐quality journal in translational neuroscience by Xunming Ji, Piotr Walczak, Heleen M. M. van Beusekom, Ana I. Casas, Andrew Clarkson, Tracy Farr, Jukka Jolkkonen, Yajie Liang, Michel M. Modo, Paulo H. Rosado‐de‐Castro, Karsten Ruscher, Yan‐Jiang Wang, Haitao Wu, Marietta Zille, Shen Li, Johannes Boltze
Published 2023-09-01Get full text
Article -
2
Associations of Plasma and CSF Osteocalcin Levels With CSF ATN Biomarkers and Cognitive Functions in Alzheimer's Disease by Xian‐Le Bu, Zhuo‐Ting Liu, Jia‐Yan Xin, Mei Huang, Yu‐Di Bai, Jin Zhou, Yun‐Yu Bao, Jiang‐Hui Li, Zhi‐Hao Liu, Gui‐Hua Zeng, An‐Yu Shi, Dong‐Wan Chen, Yu‐Jie Lai, Yang Chen, Fan Zeng, Jun Wang, Qing‐Qing Tao, Zhi‐Ying Wu, Yan‐Jiang Wang
Published 2025-07-01ABSTRACT Animal studies have shown that osteocalcin (OCN), a hormone derived from bone, plays a vital role in brain development and cognitive function. However, its potential connection to Alzheimer's disease (AD) pathology in humans remains largely unexplored. This cross‐section study included...
Get full text
Article -
3
Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI) by Jie Liu, Heleen vanBeusekom, Xian‐Le Bu, Gong Chen, Paulo Henrique Rosado de Castro, Xiaochun Chen, Xiaowei Chen, Andrew N. Clarkson, Tracy D. Farr, Yuhong Fu, Jianping Jia, Jukka Jolkkonen, Woojin Scott Kim, Paula Korhonen, Shen Li, Yajie Liang, Guang‐Hui Liu, Guiyou Liu, Yu‐Hui Liu, Tarja Malm, Xiaobo Mao, Joaquim Miguel Oliveira, Mike M. Modo, Pedro Ramos‐Cabrer, Karsten Ruscher, Weihong Song, Jun Wang, Xuanyue Wang, Yun Wang, Haitao Wu, Lize Xiong, Yi Yang, Keqiang Ye, Jin‐Tai Yu, Xin‐Fu Zhou, Marietta Zille, Colin L. Masters, Piotr Walczak, Johannes Boltze, Xunming Ji, Yan‐Jiang Wang
Published 2023-12-01Abstract The global trend toward aging populations has resulted in an increase in the occurrence of Alzheimer's disease (AD) and associated socioeconomic burdens. Abnormal metabolism of amyloid‐β (Aβ) has been proposed as a significant pathomechanism in AD, supported by results of recent clinic...
Get full text
Article